Marker Therapeutics, Inc.

Monthly Archives: August 2018

TapImmune to Participate at Two Upcoming Industry Conferences

Peter L. Hoang will be participating in two industry conferences next week.
Read More

Companies Merge to Implement Baylor College of Medicine-Developed Therapies for Cancer

The researchers developed a novel therapy for cancer patients that harnesses the patient’s own immune system to fight cancer in a natural way. This therapy uses a ‘natural’ T cell response that does not require genetic engineering.
Read More